<DOC>
	<DOC>NCT01232322</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and efficacy for long term treatment of the drug in children aged 6 months and &lt; 5 years on bronchial asthma in daily clinical usage.</brief_summary>
	<brief_title>Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Patients treated with Pulmicort Respules for the first time due to bronchial asthma Children of &gt;= 6 months and &lt; 5 years old age at the start of study treatment</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>bronchial asthma</keyword>
	<keyword>Pulmicort Respules</keyword>
	<keyword>long term use</keyword>
	<keyword>pediatrics</keyword>
</DOC>